T CELL ABNORMALITIES IN AUTOIMMUNE 1PR/1PR MICE
自身免疫 1PR/1PR 小鼠中的 T 细胞异常
基本信息
- 批准号:3158379
- 负责人:
- 金额:$ 5.75万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1988
- 资助国家:美国
- 起止时间:1988-10-01 至 1993-01-01
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION (Adapted from the applicant's abstract): MRL/Mp-lpr/lpr mice
develop a systemic lupus erythematosus (SLE) like disease similar to human
SLE and develop an age dependent lymphoproliferative disease characterized
by massive accumulation of an abnormal subset of T lymphocytes. The
abnormal lpr T cells are unresponsive to many mitogenic stimuli.
Phenotypically normal CD4+ T cells, which account for only 5 to 10 percent
of the lymphocytes in lpr mice, also play an important role in the
pathogenesis of autoimmune disease. These CD4 bearing cells may recognize
self Ia antigens or some processed self peptides bound to Ia. Interaction
of these autoreactive T cells with B cells may result in production of
autoantibodies. T cells and self-antigens may, therefore, be the cause of
autoimmune diseases in these mice. T cell hybridomas were generated by
fusing CD4+ lpr T cells with BW5147. These hybridomas will be used to
investigate the T cell receptor repertoire of the autoreactive T cells. T
cell hybridomas or their supernatants will be cultured with B cells to
determine if they can activate B cells to produce antibodies. The isotype
and specificities of antibodies produced will be determined. B cells from
lpr mice may possess some intrinsic features which render them more
stimulatory in activating autoreactive T cells. While it is clear that
CD4+ T cells are essential for the development of lymphoproliferation in
lpr mice, the relationship between CD4+ T cells and abnormal T cells is not
clear. CD4+ T cells may be the precursors of the abnormal T cells.
Lymphocytes infiltrate the kidneys and salivary glands in lpr mice. The
majority of the infiltrating lymphocytes are CD4+ T cells. T cell clones
and T cell hybridomas will be generated from infiltrating lymphocytes
obtained from the kidneys and salivary glands of lpr mice. The T cell
receptor (TCR) repertoire of these T cell clones and hybridomas will be
characterized. Antigen presenting cells in the kidneys and salivary glands
of lpr mice will also be isolated and their ability to activate the T cell
clones or hybridomas will be determined. These studies should provide new
insights into the relationship between autoreactive T cells, abnormal T
cells and lymphocytes infiltrating inflamed organs in lpr mice.
描述(改编自申请人摘要):MRL/Mp-lpr/lpr小鼠
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MAN-SUN M SY其他文献
MAN-SUN M SY的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MAN-SUN M SY', 18)}}的其他基金
Normal Cellular Prion Protein in Pancreatic Cancer
胰腺癌中的正常细胞朊病毒蛋白
- 批准号:
7446371 - 财政年份:2008
- 资助金额:
$ 5.75万 - 项目类别:
Normal Cellular Prion Protein in Pancreatic Cancer
胰腺癌中的正常细胞朊病毒蛋白
- 批准号:
7577470 - 财政年份:2008
- 资助金额:
$ 5.75万 - 项目类别:
Intercellular transfer of prion in prion disease
朊病毒病中朊病毒的细胞间转移
- 批准号:
6876633 - 财政年份:2003
- 资助金额:
$ 5.75万 - 项目类别:
Intercellular transfer of prion in prion disease
朊病毒病中朊病毒的细胞间转移
- 批准号:
6601359 - 财政年份:2003
- 资助金额:
$ 5.75万 - 项目类别:
Intercellular transfer of prion in prion disease
朊病毒病中朊病毒的细胞间转移
- 批准号:
6703137 - 财政年份:2003
- 资助金额:
$ 5.75万 - 项目类别:
Intercellular transfer of prion in prion disease
朊病毒病中朊病毒的细胞间转移
- 批准号:
7037605 - 财政年份:2003
- 资助金额:
$ 5.75万 - 项目类别:
IMMUNE RESPONSE TO HIV-1 ENCODED ANTIGENS IN MICE
小鼠对 HIV-1 编码抗原的免疫反应
- 批准号:
3141966 - 财政年份:1989
- 资助金额:
$ 5.75万 - 项目类别:
IMMUNE RESPONSE TO HIV-1 ENCODED ANTIGENS IN MICE
小鼠对 HIV-1 编码抗原的免疫反应
- 批准号:
3141968 - 财政年份:1989
- 资助金额:
$ 5.75万 - 项目类别:
IMMUNE RESPONSE TO HIV-1 ENCODED ANTIGENS IN MICE
小鼠对 HIV-1 编码抗原的免疫反应
- 批准号:
3141967 - 财政年份:1989
- 资助金额:
$ 5.75万 - 项目类别:
相似海外基金
The molecular basis of T cell receptor cross-reactivity between MHC and MR1
MHC 和 MR1 之间 T 细胞受体交叉反应的分子基础
- 批准号:
DP240102905 - 财政年份:2024
- 资助金额:
$ 5.75万 - 项目类别:
Discovery Projects
Machine Learning of Disease Biomarkers from B and T cell Receptor Repertoires
来自 B 和 T 细胞受体库的疾病生物标志物的机器学习
- 批准号:
23K28188 - 财政年份:2024
- 资助金额:
$ 5.75万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
CAREER: Understanding the Impact of Dephosphorylation Kinetics and Adapter Specificity on Synthetic T Cell Receptor Signaling and Function
职业:了解去磷酸化动力学和接头特异性对合成 T 细胞受体信号传导和功能的影响
- 批准号:
2339172 - 财政年份:2024
- 资助金额:
$ 5.75万 - 项目类别:
Continuing Grant
Special Public T Cell Receptor Sequences that Predict Outcomes for Cancer Patients
预测癌症患者预后的特殊公共 T 细胞受体序列
- 批准号:
10577518 - 财政年份:2023
- 资助金额:
$ 5.75万 - 项目类别:
Machine Learning of Disease Biomarkers from B and T cell Receptor Repertoires
来自 B 和 T 细胞受体库的疾病生物标志物的机器学习
- 批准号:
23H03498 - 财政年份:2023
- 资助金额:
$ 5.75万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Impact of T cell receptor signaling on memory CD8+ T cell stemness
T 细胞受体信号传导对记忆 CD8 T 细胞干性的影响
- 批准号:
10676407 - 财政年份:2023
- 资助金额:
$ 5.75万 - 项目类别:
T cell receptor cross-reactivity and structural basis of virus immune escape
T细胞受体交叉反应性和病毒免疫逃逸的结构基础
- 批准号:
22KK0277 - 财政年份:2023
- 资助金额:
$ 5.75万 - 项目类别:
Fund for the Promotion of Joint International Research (Fostering Joint International Research (A))
T-cell receptor mimic affinity reagent generation using an in vivo novel immunogen strategy
使用体内新型免疫原策略生成 T 细胞受体模拟亲和试剂
- 批准号:
10599584 - 财政年份:2023
- 资助金额:
$ 5.75万 - 项目类别:
Mechanical regulation of T cell receptor and co-receptor responses in cancer immunotherapy
癌症免疫治疗中 T 细胞受体和辅助受体反应的机械调节
- 批准号:
10530023 - 财政年份:2022
- 资助金额:
$ 5.75万 - 项目类别:
Inhibition of T-cell Receptor Signaling for Treatment of Adult T-cell Leukemia Lymphoma
抑制 T 细胞受体信号转导治疗成人 T 细胞白血病淋巴瘤
- 批准号:
10684172 - 财政年份:2022
- 资助金额:
$ 5.75万 - 项目类别:














{{item.name}}会员




